Overview
Orchid Orthopedic Solutions provides end-to-end manufacturing services for orthopedic implants. It partners with original equipment manufacturers (OEMs) to handle the full process—from initial design and precision manufacturing to applying coatings and final packaging—so OEMs can streamline their supply chains for hip, knee, and spinal implants. The company differentiates itself by acting as a global, behind‑the‑scenes supplier with an integrated suite of capabilities, enabling a one‑stop source for implant components and related services. Orchid’s goal is to be a global leader in orthopedic manufacturing by delivering reliable, scalable components and processes that power the orthopedic industry.
Work here?Claim your company
Simplify's take
What believers are saying
- May 14, 2026 closing increased scale, capacity, and product-lifecycle coverage for OEMs.
- Combined company reported 3,500 employees and about $781 million 2025 revenue.
- Andreas Weller now leads a stronger global footprint with expanded design and manufacturing services.
What critics are saying
- Integration risk starts now; phased consolidation can disrupt delivery, quality, and customer relationships.
- Robert Lankton v. Orchid Orthopedic Solutions returned to court June 17, 2026, highlighting HR exposure.
- Orchid is now subsumed under Tecomet, so brand dilution threatens direct OEM preference.
What makes Orchid Orthopedic Solutions unique
- May 14, 2026 merger with Tecomet created a broader orthopedic and aerospace platform.
- Orchid’s coatings, forging, casting, and additive manufacturing remain rare among orthopedic suppliers.
- Ten facilities across the U.S., U.K., and Switzerland support OEM supply continuity.
Help us improve and share your feedback! Did you find this helpful?